Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,323 papers from all fields of science
Search
Sign In
Create Free Account
hTERT-encoding DNA Vaccine INVAC-1
Known as:
INVAC-1
A DNA vaccine consisting of a plasmid encoding a modified, inactive form of the human telomerase reverse transcriptase (hTERT), the catalytic subunit…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Cytotoxic T-Lymphocytes
T-Cell Activation
immunopotentiation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Final results of a phase I study evaluating INVAC-1, a novel DNA vaccine expressing an inactive form of human telomerase reverse transcriptase (hTERT) in patients with advanced solid tumors.
L. Teixeira
,
J. Medioni
,
+16 authors
P. Demoyen
Journal of Clinical Oncology
2019
Corpus ID: 190900513
2642 Background: INVAC-1 is an optimized DNA plasmid encoding an inactive form of human Telomerase Reverse Transcriptase (hTERT…
Expand
2017
2017
Results of a first-in-human phase I study of INVAC-1, an optimized plasmid DNA encoding an inactive form of human telomerase reverse transcriptase (hTERT), in patients with advanced solid tumors.
L. Teixeira
,
J. Medioni
,
+11 authors
P. Langlade‐Demoyen
2017
Corpus ID: 81862192
3087Background: INVAC-1 is an optimized plasmid encoding an inactive form of human telomerase reverse transcriptase (hTERT…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE